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Extracellular Signal-Regulated Kinase Activation Critical
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Immunoglobulin E (IgE) induces mast cell survival in the absence of antigen (Ag) through the high-affinity
IgE receptor, Fc receptor I (FcRI). Although we have shown that protein tyrosine kinase Syk and sustained
extracellular signal-regulated kinase (Erk) activation are required for IgE-induced mast cell survival, how Syk
couples with sustained Erk activation is still unclear. Here, we report that the transmembrane adaptors LAT
and NTAL are phosphorylated slowly upon IgE stimulation and that sustained but not transient Erk activation
induced by IgE was inhibited in LAT/ NTAL/ bone marrow-derived mast cells (BMMCs). IgE-induced
survival requires Ras activation, and both were impaired in LAT/ NTAL/ BMMCs. Sos was preferentially
required for FcRI signals by IgE rather than IgE plus Ag. Survival impaired in LAT/ NTAL/ BMMCs
was restored to levels comparable to those of the wild type by membrane-targeted Sos, which bypasses the
Grb2-mediated membrane recruitment of Sos. The IgE-induced survival of BMMCs lacking Gads, an adaptor
critical for the formation of the LAT–SLP-76–phospholipase C (PLC) complex, was observed to be normal.
IgE stimulation induced the membrane retention of Grb2-green fluorescent protein fusion proteins in wild-type
but not LAT/ NTAL/ BMMCs. These results suggest that LAT and NTAL contribute to the maintenance
of Erk activation and survival through the membrane retention of the Ras-activating complex Grb2-Sos and,
further, that the LAT–Gads–SLP-76–PLC and LAT/NTAL-Grb2-Sos pathways are differentially required for
degranulation and survival, respectively.
Immunoglobulin E (IgE) binding to its high-affinity recep-
tor, Fcε receptor I (FcεRI), is usually considered to be a pas-
sive step called sensitization. However, recent studies have
shown that IgE actively promotes several mast cell responses,
such as survival, adhesion, and the promotion of in vivo in-
flammatory reactions in the absence of antigen (Ag) (3, 6, 16,
17, 26). Furthermore, high concentrations of IgE (10 g/ml)
in the plasma of subjects with parasitic infections or atopic
diseases have often been observed (18), suggesting a possible
Ag-independent contribution of IgE to the exacerbation of
these diseases. Recent studies have suggested that IgE may
elicit weak FcεRI aggregation to induce mast cell responses,
even in the absence of multivalent Ag (22, 23). IgE-induced
responses in the presence and absence of Ag are known to
utilize distinct signaling pathways; by manipulating the dura-
tion of extracellular signal-regulated kinase (Erk) activation,
we previously showed that sustained Erk activation is critical
for mast cell survival but not for degranulation (52). Although
we and others have also found that IgE-induced mast cell
survival requires Fc receptor -ITAM, Lyn, and Syk (21, 22, 24,
40), the molecular mechanism underlying the coupling of Syk
with sustained Erk activation is still unclear.
Many reports have demonstrated that the duration of Erk
activation alters the quality of biological responses (29, 30, 52).
In a variety of receptor systems, Erk activation is regulated by
Ras through the subsequent activation of Raf and mitogen-
activated protein kinase/Erk kinase (MEK). Although Ras is
activated by guanine nucleotide exchange factors (GEFs) such
as Sos upon growth factor stimulation (7), recent reports have
suggested that another GEF, RasGRP, also activates Ras in
T-cell receptor (TCR)- or B-cell receptor (BCR)-mediated
signaling (10, 32). RasGRP is activated by diacylglycerol, a
product of phospholipase C (PLC)-mediated hydrolysis
(11), providing a new pathway for Ras activation from Ag
receptors. However, the contributions of Sos and RasGRP to
FcεRI signaling through IgE in the presence and absence of Ag
are still unknown.
NTAL (5), also called LAB (15), and LAT are raft-localized
transmembrane adaptor molecules possessing multiple ty-
rosine-based activation motifs, and they are the substrates for
Syk (13, 36). Although Grb2 and Gads binding motifs are
conserved in both proteins, the binding site for PLC is present
only in LAT and not in NTAL (5, 8, 14). It has been demon-
strated previously that LAT is critical for mast cell activation
upon IgE stimulation in the presence of Ag (38). On the other
hand, NTAL has been reported to function as a negative reg-
ulator as well as a positive regulator of FcεRI signaling in mast
cells upon IgE-Ag stimulation (43, 47, 57). The analysis of
bone marrow-derived mast cells (BMMCs) has led to the pro-
posal of a possible mechanism for the molecular competition
between the two proteins within the lipid raft, which may
* Corresponding author. Mailing address: 1-7-22 Suehiro-cho, Tsu-
rumi-ku, Yokohama, Kanagawa 230-0045, Japan. Phone: 81-45-503-
7037. Fax: 81-45-503-7036. E-mail: saito@rcai.riken.jp.
 Published ahead of print on 9 April 2007.
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explain how NTAL exerts a negative regulatory function in a
LAT-dependent manner (47, 57).
Using BMMCs deficient in both LAT and NTAL, we
showed that these two adaptors contribute to IgE-induced
sustained Erk activation and survival by acting as a scaffold for
the retention of the Grb2-Sos complex within the plasma mem-
brane.
MATERIALS AND METHODS
Mice. LAT/, NTAL/, and LAT/ NTAL/ mice with a C57BL/6
background have been described previously (47). Syk/ mice with a BALB/c
background were provided by V. L. J. Tybulewicz (24). Gads/ mice with a
C57BL/6 and 129 mixed genetic background have been described previously (56).
All mice were maintained under specific-pathogen-free conditions in accordance
with institutional guidelines.
Abs. The mouse anti-dinitrophenol IgE antibody (Ab) H1-DNP-ε-26 was
kindly provided by F.-T. Liu and T. Kawakami (La Jolla Institute, Ontario, CA)
and used for survival assays. The mouse antidinitrophenol IgE Ab SPE-7 was
purchased from Sigma (St. Louis, MO) and used for survival assays and bio-
chemistry analyses. For IgE stimulation, each IgE clone was ultracentrifuged at
100,000  g for 10 min just before use in the assays in order to exclude aggre-
gates, as described previously (24, 33). Anti-phospho-Erk Ab was purchased
from Promega (Madison, WI), anti-phospho-Syk was from Cell Signaling Tech-
nology (Beverly, MA), antiactin was obtained from Sigma, anti-phospho-PLC
was from Biosource International (Camarillo, CA), anti-Ras was purchased from
Pierce Biotechnology (Rockford, IL), anti-green fluorescent protein (anti-GFP)
was obtained from Invitrogen (Carlsbad, CA), anti-GFP–horseradish peroxidase
(HRP) was from Miltenyi Biotec (Bergisch, Gladbach, Germany), anti-mouse
IgG–HRP and protein G-Sepharose were purchased from Amersham Bio-
sciences (Piscataway, NJ), anti-rabbit Ig–HRP was from Zymed (San Francisco,
CA), and anti-Sos Ab was obtained from BD Pharmingen (San Diego, CA).
Anti-mCD63 monoclonal Ab, which has been proven to be specific to CD63 by
using CD63 transfectant, was kindly provided by K. Nishida (RIKEN, Yoko-
hama, Japan). Anti-NTAL Abs were kindly provided by V. Horejsi (Academy of
Science of the Czech Republic, Prague).
Construction. To construct the Grb2-GFP fusion, the Grb2 gene was fused to
that for GFP by PCR. Genes for RasN17 and farnesylated Sos, which were kindly
provided by K. Nishida (RIKEN, Yokohama, Japan) and A. Aronheim (Israel
Institute of Technology, Haifa, Israel) (1), respectively, were cloned into the
pMX-IRES-hCD8 (53) or pMX-IRES-GFP retroviral vector. Glutathione S-
transferase (GST)–Raf–Ras binding domain (RBD) was kindly provided by J. L.
Bos (University Medical Center Utrecht, Utrecht, The Netherlands) (9). For the
construct comprising the proline-rich domains of Sos (Sos-Pro), the region of the
Sos gene corresponding to amino acids 1,019 to 1,336 was amplified by PCR and
subcloned into pMX-IRES-GFP (20).
Retroviral infection and BMMC induction. The preparation of BMMCs and
fetal liver-derived mast cells and the retroviral infection of BMMCs were carried
out as previously described (24, 52). Adherent cells were removed every 3 to 5
days. After 4 weeks, homogeneous populations of FcεRI-positive, c-kit-positive
BMMCs were obtained. For the infection of differentiated BMMCs, cells were
cultured with 100 ng of stem cell factor/ml and 30 ng of interleukin-3 (IL-3)/ml
for 12 h and then spin infected with concentrated virus supernatant.
Western blotting. BMMCs were cultured without IL-3 for 2 h and then stim-
ulated with IgE (SPE-7) at 37°C for the times indicated below. Cells were lysed
in lysis buffer containing 1% Nonidet P-40 and subjected to Western blotting as
previously described (52).
Survival assays. BMMCs (2  105) were washed with IL-3-free medium twice
and then stimulated with IgE (H1-DNP-ε-26 and SPE-7) in 400 l of IL-3-free
medium on 48-well plates. Forty-microliter samples of the cultured cells were
taken daily and stained with propidium iodide, and live cells were counted with
a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA). Live-cell gating
was performed on FL3 (propidium iodide)-side-scatter dot plots, which can
separate out live cell populations clearly.
Real-time reverse transcription-PCR (RT-PCR). BMMCs were incubated in
the absence of IL-3 for 1 h and then stimulated with IgE for 1 h. RNA was
isolated by using an RNeasy minikit (QIAGEN, Valencia, CA). After the re-
moval of genomic DNA by treatment with DNase (Wako Nippon Gene, Tokyo,
Japan), randomly primed cDNA strands were generated with reverse transcrip-
tase II (Invitrogen). By using gene-specific primers, RNA expression was quan-
tified by real-time PCR, and values were normalized to -actin expression.
FIG. 1. LAT and NTAL are phosphorylated by IgE (without Ag)
and are required for sustained Erk activation. (A and B) Syk/ (WT)
and littermate Syk/ (Syk KO) fetal liver-derived mast cells were
stimulated with 10 g of IgE/ml for the indicated periods, and total cell
lysates were blotted with antibodies to phospho-Erk (anti-pErk) and
Erk (A) and phosphotyrosine (anti-pY) and phospho-LAT (anti-
pLAT) (B). Brackets on the right indicate LAT (upper) and NTAL
(lower). Numbers on the left are molecular size markers. (C) C57BL/6
(WT) and NTAL/ (NTAL KO) BMMCs were stimulated as de-
scribed above. Total cell lysates were blotted with antiphosphotyrosine.
(D) IgE (in the presence of Ag) induces transient phosphorylation and
Erk activation. BMMCs were sensitized with 1 g of IgE/ml for 4 h and
then stimulated with 15 ng of DNP-HSA/ml. Cell lysates were blotted
with antibodies to phosphotyrosine, phoshpo-Erk, and Erk.
VOL. 27, 2007 ROLE OF LAT AND NTAL IN MAST CELL SURVIVAL 4407
 o
n
 January 10, 2014 by W
ashington University in St. Louis
http://m
cb.asm
.org/
D
ow
nloaded from
 
Gene-specific primer sequences were as follows: -actin gene, 5-TGGAAT
CCTGTGGCATCCATGAAAC-3 (forward) and 5-TAAAACGCAGCTCA
GTAACAGTCCG-3 (reverse); IL-3 gene, 5-ATAGGGAAGCTCCCAGA
ACCTGAACTC-3 (forward) and 5-AGACCCCTGGCAGCGCAGAGTCA
TTC-3 (reverse); and histidine decarboxylase gene, 5-AGTCTGGCGAGA
AGGGAAGG-3 (forward) and 5-TCTGGGCACTCATAGGCACA-3
(reverse).
Pulldown assay. BMMCs were lysed with lysis buffer (Ras activation kit;
Pierce, Rockford, IL). Cell lysates were incubated with GST-Raf-RBD-bound
glutathione-Sepharose for 1 h at 4°C. After the samples had been washed five
times with lysis buffer, Sepharose-bound protein was eluted with 10 mM gluta-
thione and analyzed by Western blotting with anti-Ras Ab.
Flow cytometric analysis of degranulation. Degranulation was analyzed by
flow cytometry as described previously (31). Briefly, BMMCs were sensitized
with 1 g of IgE (SPE-7)/ml for 4 h and then stimulated with 50 ng of dinitro-
phenol-conjugated human serum albumin (DNP-HSA)/ml for 30 min in Tyrode’s
buffer. Cells were fixed with 4% paraformaldehyde for 15 min and then stained
with anti-CD63 Ab and phycoerythrin-conjugated goat anti-mouse IgG (heavy-
and light-chain) Fab (Cedarlane, Ontario, Canada). The surface expression of
CD63 was determined by flow cytometry.
Microscopic analysis. BMMCs were infected with pMX-Grb2/GFP-IRES-
hCD8. After being sorted with anti-human CD8 (anti-hCD8), the cells were
stimulated with immobilized IgE (SPE-7; 10 g/ml) on a glass-coated dish (Mat-
Tech, Ashland, MA). After 30 min of incubation at 37°C, the cells were analyzed
FIG. 2. LAT and NTAL are required for sustained Erk activation. (A) Activation of Erk upon IgE stimulation. C57BL/6 (WT), LAT/ (LAT
KO), NTAL/ (NTAL KO), and LAT/ NTAL/ (dKO) BMMCs were stimulated with 10 g of IgE/ml, and total cell lysates were
immunoblotted with anti-phospho-Erk and anti-Erk. (B) Quantitative results of the analysis of phospho-Erk described in the legend to panel A.
The intensity of each band shown in panel A was quantified, and the values are expressed as arbitrary units (a.u.). (C) Activation of Syk upon IgE
stimulation. BMMCs were treated as described in the legend to panel A and blotted with anti-phospho-Syk and anti-Syk. (D) Activation of Erk
upon Ag cross-linking. WT and dKO BMMCs were stimulated as described in the legend to Fig. 1D and blotted with anti-phospho-Erk and
anti-Erk. Data are representative of findings from three independent experiments with similar results.
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by wide-field fluorescence microscopy with an IX-81 instrument (Olympus, To-
kyo, Japan). The membrane localization of Grb2-GFP was assessed by total
internal reflection fluorescence (TIRF) microscopy with an IX81-ARCEVA
system (Olympus, Tokyo, Japan).
RESULTS
LAT and NTAL are required for sustained Erk activation by
IgE in the absence of Ag. IgE induces sustained Erk activation
in mast cells in the absence of Ag (16, 52), whereas Erk acti-
vation in Syk/ mast cells was totally abolished (Fig. 1A, right
lanes). To assess how Syk couples with sustained Erk activation
upon IgE stimulation in the absence of Ag, we first examined
the total tyrosine phosphorylation pattern induced in mast cells
by IgE treatment without Ag. The phosphorylation of two
major proteins, pp36 and pp30-32, was observed upon IgE
treatment with slow kinetics (Fig. 1B, upper panel). These
phospho-proteins were not detected in Syk/ mast cells (Fig.
1A, right lanes), suggesting that they are substrates or are
located downstream of Syk. pp36 was likely to be LAT, be-
cause the anti-phospho-LAT blot exhibited similar results (Fig.
1B, lower panel), whereas pp30-32 seemed to correspond to
NTAL on the basis of its gel mobility pattern (5, 15, 47) and the
anti-NTAL immunoblot (data not shown). Indeed, pp30-32
was completely absent in NTAL/ BMMCs (Fig. 1C). These
results are consistent with the report that LAT and NTAL are
expressed in mast cells and are substrates for Syk (5). The
phosphorylation of these two adaptors was also elicited, albeit
to a lesser extent in the case of NTAL, upon IgE stimulation in
the presence of Ag (Fig. 1D) as reported previously (47, 57).
However, the levels of phosphorylation of these adaptors rap-
idly declined after 5 min (Fig. 1D). Thus, LAT and NTAL are
phosphorylated with slow kinetics upon IgE stimulation in the
absence of Ag, in sharp contrast to the transient phosphoryla-
tion upon IgE stimulation in the presence of Ag (57).
Next, to examine the role of LAT and NTAL in IgE-induced
sustained Erk activation, we stimulated BMMCs from wild-
type (WT), LAT/, NTAL/, and LAT/ NTAL/ (dou-
ble knockout [dKO]) mice with IgE in the absence of Ag. The
absence of LAT and/or NTAL did not alter the level of surface
expression of FcεRI in BMMCs (data not shown), consistent
with results in previous reports (47, 57). We compared the
kinetics of downstream signaling in these BMMCs after stim-
ulation by IgE in the absence of Ag (Fig. 2A, B, and C) and in
the presence of Ag (Fig. 2D). Although LAT plays a critical
role in IgE-induced mast cell responses in the presence of Ag
(38), sustained Erk activation by IgE in LAT/ BMMCs was
slightly reduced but still observed. In contrast, dKO BMMCs
showed severe impairment of sustained Erk activation, al-
though transient activation was almost normal (Fig. 2A and B).
A minor role for LAT and NTAL in transient Erk activation
was also evident upon FcεRI stimulation by Ag cross-linking
(Fig. 2D) (57). The intensity of Erk activation in NTAL/
BMMCs was augmented (Fig. 2A and B), consistent with the
reports that NTAL negatively regulates mast cell responses
FIG. 3. LAT and NTAL are required for IgE-induced survival and IL-3 production. (A) IgE-induced survival of C57BL/6 (WT), LAT/ (LAT
KO), NTAL/ (NTAL KO), and LAT/ NTAL/ (dKO) BMMCs. Cells were stimulated with 1 g of IgE/ml in the absence of IL-3, and cell
viability at the indicated periods was determined by propidium iodide staining. Data are means	 standard deviations (SD) of results from triplicate
assays and are representative of findings from four independent experiments with similar results. (B) IL-3 mRNA expression. BMMCs were
incubated without IL-3 for 1 h and were left unstimulated or were stimulated with IgE for 1 h. RNA was isolated, and levels of expression of IL-3
mRNA were determined by real-time RT-PCR. Levels of mRNA expression are relative to that in unstimulated WT BMMCs.
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induced by IgE in the presence of Ag (47, 57). The level of Syk
phosphorylation, as an upstream event, in dKO BMMCs was
not decreased (Fig. 2C). These results indicate that IgE-in-
duced Erk activation can be triggered but not sustained in the
absence of LAT and NTAL even when FcεRI engagement and
Syk activation are prolonged.
LAT and NTAL are required for IgE-induced mast cell sur-
vival and IL-3 induction. We then analyzed the contribution of
LAT and NTAL to IgE-induced survival. The survival of
LAT/ BMMCs was slightly impaired, but that of LAT/
NTAL/ BMMCs was almost completely inhibited (Fig. 3A),
an observation that was well correlated with the degree of
sustained Erk activation (Fig. 2). We have previously shown
that autocrine IL-3 production plays a critical role in IgE-
induced mast cell survival (24). Indeed, the induction of IL-3
mRNA in LAT/ NTAL/ BMMCs was greatly impaired
(Fig. 3B). Furthermore, other events elicited by IgE stimula-
tion in the absence of Ag, such as IL-6 production and histidine
decarboxylase induction, were also blocked in LAT/
NTAL/ BMMCs (data not shown). Taken together, these
results show that NTAL and LAT are crucial for IgE-mediated
IL-3 induction and mast cell survival in the absence of Ag. The
results were consistent when another IgE clone, SPE-7, was
used (data not shown).
Ras activation through LAT and NTAL is critical for mast
cell survival. We next examined how sustained Erk activa-
tion was maintained through LAT and NTAL. The activation
of MEK, a kinase upstream of Erk, in LAT/ NTAL/
BMMCs was also impaired (data not shown). Since both LAT and
NTAL are capable of binding Grb2, an event that potentially
leads to MEK activation through Sos and Ras (5), we investi-
gated Ras activation upon IgE stimulation in the absence
of Ag. IgE binding induced sustained Ras activation in WT
BMMCs, whereas the activation in LAT/ NTAL/ BMMCs
was greatly diminished (Fig. 4A). To examine the role of Ras
activation in IgE-induced survival, a dominant negative form of
Ras (RasN17) was introduced into WT BMMCs. RasN17 mark-
edly suppressed IgE-induced BMMC survival and IL-3 pro-
duction (Fig. 4B and C), although the rates of exogenous
IL-3-induced survival did not differ between mock- and RasN17-
transduced cells (data not shown). These results suggest that
LAT and NTAL regulate IgE-induced survival through sus-
tained Ras activation.
We next analyzed the involvement of Sos in survival through
Ras activation. If LAT and NTAL were to serve as a platform for
the sustained localization of the Grb2-Sos complex within the
plasma membrane, the existence of a membrane-targeted form of
Sos would bypass the requirement for LAT and NTAL. Indeed,
the expression of farnesylated Sos was able to abolish the defect
in IgE-induced survival among LAT/ NTAL/ BMMCs and
restore the survival rates to levels comparable to those of WT
BMMCs (Fig. 4D). On the other hand, if Sos was required for
IgE-induced survival, then Sos-Pro, which is known to block
Grb2-Sos interaction (46), would suppress this event. Indeed,
Sos-Pro suppressed mast cell survival induced by IgE in the ab-
sence of Ag (Fig. 4E). Collectively, sustained Ras activation by
the prolonged membrane targeting of Sos through LAT and
NTAL seems to be necessary and sufficient for mast cell survival.
To verify if Sos also contributes to the IgE-mediated signal
in the presence of Ag, we examined the effect of Sos-Pro on
degranulation induced by IgE in the presence of Ag by ana-
lyzing CD63 expression on the cell surface as a marker for
degranulation (31). Surprisingly, the levels of induction of sur-
face CD63 expression in GFP-negative (control) and GFP-
positive (Sos-Pro) cells were similar (Fig. 4F). Thus, in the
absence of Ag the Sos-Ras pathway is preferentially required
for IgE-induced events as a downstream component of LAT
and NTAL.
The Gads-mediated pathway is not essential for IgE-induced
mast cell survival. In addition to Grb2, LAT and NTAL can bind
Gads, an adaptor molecule that is similar to Grb2 and contains
Src homology 3 (SH3)-SH2-SH3 domains. Gads is essential for
linking LAT and SLP-76 (2) and is critical for TCR-mediated
PLC1 activation and Ca2 influx (56). It was recently reported
that PLC also contributes to Ras activation through RasGRP, a
diacylglycerol-dependent GEF. To examine the contribution of
the Gads-mediated pathway to IgE-induced responses in the ab-
sence of Ag, we analyzed Gads/ BMMCs. PLC activation in
Gads/ BMMCs was impaired, as expected (Fig. 5A). However,
levels of sustained Erk activation, Ras activation, and mast cell
survival in Gads/ BMMCs were observed to be comparable to
those in WT BMMCs (Fig. 5). Thus, although LAT and NTAL
FIG. 4. NTAL and LAT mediate sustained Ras activation critical for survival induction. (A) Activation of Ras upon IgE stimulation. BMMCs
were cultured in the absence of IL-3 for 2 h at 37°C, followed by stimulation with 10 g of IgE/ml. Total cell lysates were pulled down with
GST-Raf-RBD, and the amount of activated Ras was determined by immunoblotting with anti-Ras Ab (upper panel) and anti-GST to confirm the
amount of GST protein used (middle panel). The ratio of the intensity of anti-Ras to that of anti-GST was calculated and expressed as Ras activity
(bar chart). Total lysates were also subjected to immunoblotting with anti-Ras Ab (bottom panel). LAT KO, LAT/ BMMCs; NTAL KO,
NTAL/ BMMCs. (B) Effect of dominant negative Ras on IgE-induced survival of BMMCs. Mature WT BMMCs were infected with the
pMX-IRES-GFP vector alone (mock) or dominant negative Ras (Ras N17). After 2 days, cells were left unstimulated (open circles) or were
stimulated with 1 g of IgE/ml (closed circles) in the absence of IL-3 and the viability of GFP-positive BMMCs was determined by flow cytometry.
For each treatment, data are expressed as the percentages of viable cells relative to the population of viable cells at day 0. Means 	 SD of results
from triplicate assays are shown. (C) Dominant negative Ras suppresses IgE-induced IL-3 production. WT BMMCs were infected with pMX-
RasN17-IRES-hCD8. hCD8 (control) and hCD8 cells were sorted and stimulated with 10 g of IgE/ml for 4 h. (D) Effect of membrane-targeted
Sos on IgE-induced survival. WT and dKO BMMCs were infected with the pMX-IRES-GFP vector only (mock) or farnesylated Sos (Far-Sos), and
survival upon IgE stimulation was assessed as described in the legend to panel B. Data are means 	 SD of results from triplicate assays. ns, not
significant; *, P 
 0.05; **, P 
 0.01 (Student’s t test). (E) Effect of dominant negative Sos (Sos-Pro) on IgE-induced survival. WT BMMCs were
infected with the pMX-IRES-GFP vector alone (mock) or dominant negative Sos, and survival induced by 1 g of IgE/ml was assessed. Data are
means 	 SD of results from triplicate assays. (F) Effect of dominant negative Sos on degranulation by IgE (with Ag). WT BMMCs infected with
pMX-Sos-Pro-IRES-GFP were left unstimulated or were stimulated with IgE and DNP-HSA. The surface expression of CD63 was determined for
GFP-negative (control) and GFP-positive (Sos-Pro) populations from the same culture. Data are representative of findings from three independent
experiments with similar results.
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can potentially bind both Grb2 and Gads, Gads seems to play a
minor role in IgE-induced sustained Erk activation and mast cell
survival in the absence of Ag. In contrast, we recently found that
IgE-induced degranulation in the presence of Ag in Gads/
mice is impaired (S. Yamasaki, O. Kanagawa, and T. Saito, un-
published data).
LAT and NTAL are required for membrane targeting of
Grb2. Finally, to confirm the contribution of LAT and NTAL
to the retention of the Grb2-Sos complex close to the inner
leaflet of the plasma membrane, we visualized the intracellular
trafficking of Grb2 by IgE by using Grb2-GFP fusion protein.
Grb2, through its SH3 domain, is constitutively associated with
Sos (35), and Grb2-GFP retained a strong affinity for endog-
enous Sos in mast cells (Fig. 6A). WT and LAT/ NTAL/
BMMCs were retrovirally transfected with Grb2-GFP, and in-
tracellular trafficking was analyzed by fluorescence microscopy.
We have previously shown that plate-coated IgE stimulation
can deliver a sustained signal similar to that of soluble IgE in
the absence of Ag (52). Stimulation on a plate coated with IgE
induced drastic membrane localization of Grb2-GFP within 30
min (Fig. 6B). To analyze the cell surface area more precisely
on an evanescent excitation field, we employed TIRF micros-
copy, because it enables a selective visualization of the plasma
membrane (4, 44). The recruitment of Grb2-GFP to the
plasma membrane was clearly observed upon IgE stimulation
(Fig. 6C, upper panels). In sharp contrast, Grb2-GFP in
LAT/ NTAL/ BMMCs did not show membrane translo-
cation (Fig. 6C, lower panels). Importantly, equal levels of
Grb2-GFP expression in WT and LAT/ NTAL/ BMMCs
were confirmed by flow cytometry (data not shown). These
results suggest that LAT and NTAL provide an essential scaf-
fold for the IgE-induced membrane retention of the Grb2-Sos
complex.
DISCUSSION
We investigated the molecular mechanism of IgE-induced
sustained Erk activation and mast cell survival. Many reports
have demonstrated that the duration of Erk activation alters
the quality of the biological response (29, 30, 52). By manip-
ulating the duration of Erk activation, we showed previously
that sustained, not transient, Erk activation is critical for mast
cell survival (52). However, how the signal duration is phy-
siologically regulated remains to be elucidated. It has been
reported previously that the duration of Erk activation is
determined by multiple mechanisms, such as receptor internal-
ization and the operation of a feedback inhibitory mechanism
(34, 41). The weak cross-linking of FcεRI without internaliza-
tion may induce sustained Erk activation through prolonged
FcεRI ligation (23, 52, 54). Nevertheless, even when FcεRI
engagement and Syk activation were prolonged, sustained Erk
activation in LAT/ NTAL/ BMMCs was almost com-
pletely inhibited, suggesting that the two adaptors LAT and
NTAL constitute some kind of timer for downstream signaling.
Note that transient Erk activation was not dramatically im-
paired by IgE stimulation in the absence of Ag (Fig. 2A and B)
and in the presence of Ag (Fig. 2D) (57) in the absence of LAT
and NTAL. This result suggests that transient Erk activation
via FcεRI is LAT- and NTAL-independent and that the weak
and prolonged cross-linking of FcεRI may preferentially utilize
LAT and NTAL for sustained Erk activation, eventually lead-
ing to mast cell survival. However, so far we cannot directly
exclude the possible contribution of another pathway to sus-
tained Erk activation, such as the activation of Rap1, B-Raf, or
protein kinase C, as reported previously (19, 41, 45).
Oh-hora et al. showed the differential requirements for Ras-
FIG. 5. The Gads-mediated PLC pathway is not required for sus-
tained Erk activation and survival. (A) IgE-induced survival of Gads/
BMMCs. WT and Gads/ BMMCs were stimulated with 1 g of IgE/ml
in the absence of IL-3, and cell viability was determined as described in
the legend to Fig. 3A. Data are means 	 SD of results from triplicate
assays and are representative of findings from three independent experi-
ments with similar results. (B) Phosphorylation of Erk and PLC upon
IgE stimulation. WT and Gads/ (Gads KO) BMMCs were stimulated
with 10 g of IgE/ml, and total cell lysates were immunoblotted with
anti-phospho-Erk (anti-pErk) and anti-phospho-PLC Abs. Actin was
also detected with anti-actin Ab (lower panel). (C) Activation of Ras upon
IgE stimulation. WT and Gads/ BMMCs were stimulated with IgE, and
the amount of activated Ras was determined in a manner similar to that
described in the legend to Fig. 4A.
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GRP and Sos in BCR- and epidermal growth factor receptor-
mediated Ras activation, respectively, by using chicken B-cell
lines (32). Our observation that dominant negative Sos sup-
presses IgE-mediated survival in the absence of Ag but not
IgE-induced degranulation in the presence of Ag implies the
existence of similar divergence patterns in FcεRI signaling;
weak, constitutive engagement but not Ag cross-linking of
FcεRI may result in the preferential utilization of Sos rather
than RasGRP for Ras activation. Although RasGRP4 is ex-
pressed in mast cells (55), the lack of Gads or LAT—important
in regulating PLC through the formation of the LAT–Gads–
SLP-76–PLC quaternary complex (27, 42, 51)—did not result
in severe impairment of sustained Erk activation, suggesting
that PLC-dependent RasGRP4 activation may not play a
major role in the maintenance of IgE-induced signals in mast
cells in the absence of Ag. Considering that LAT/ mice
exhibited severe impairment of IgE-induced mast cell degran-
ulation in the presence of Ag (38, 57), NTAL appears to
compensate for LAT function preferentially under stimulation
via IgE without Ag. This finding may be explained by the fact
that NTAL possesses binding sites for Grb2 but not for PLC,
which is crucial for degranulation (48, 49). Consistent with this
suggestion, Y136, a PLC binding site of LAT, has been shown
to be essential for degranulation (28, 39).
Recently, accumulating evidence has suggested that the
quantity and duration of signals through immune receptors
determine distinct immune responses (29, 50). It is attractive to
speculate that, likewise, the differential contributions of Sos
and RasGRP are also operative in Ras activation during sus-
tained Ag receptor triggering, for example, during the tonic
signal of BCR (25), TCR engagement for homeostatic prolif-
eration (12), or autonomous pre-TCR signaling (53). Indeed,
RasGRP1-deficient thymocytes display no apparent defect in
autonomous pre-TCR signaling, a process that is known to
depend on Ras activation (10, 37).
The augmentation of mast cell function by the genetic de-
letion of NTAL alone has been explained by an increase in the
amount of available LAT (47, 57), in light of the possible
competition between the two transmembrane adaptors within
the lipid raft. In line with these speculations, IgE-induced
events in the absence of Ag are also upregulated in NTAL/
BMMCs. As an additional possible explanation, we found that
specific chemokine receptors are constitutively upregulated in
NTAL/ BMMCs (S. Yamasaki and T. Saito, unpublished
data); this upregulation may also contribute to the augmented
mast cell responses seen in NTAL-deficient single-knockout
mice.
Taking these findings together, we propose herein a possible
molecular mechanism by which Syk couples with sustained Erk
activation upon IgE stimulation in the absence of Ag. IgE
without Ag induces the delayed phosphorylation of LAT and
NTAL. Phosphorylated LAT and NTAL may serve as a dock-
ing platform that enables the retention of the Grb2-Sos com-
plex within the plasma membrane. Thus, FcεRI can differen-
tially utilize the intracellular signaling machinery in response
to different stimuli, and the raft-localized membrane adaptors
LAT and NTAL are the critical transducers for timing the
duration of signals from FcεRI to trigger downstream events.
These results suggest that it may be possible to differentially
modulate signaling events through FcεRI in order to block
specific allergic reactions.
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